Key facts
- Notable investors include Yunfeng Capital, Guangdong Boji Venture Capital Management, Shenzhen HTI Group, Shenzhen Qianhai Greatwall Fund.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Chenghui Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Chenghui Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Chenghui Medical
Developer of medical imaging technology intended for microfluidic-based nucleic acid analysis. The company offers compact analytical devices, integrated microfluidic workflows, automated reaction and detection functions, and reagent systems that support accurate on-site molecular testing across diverse clinical environments, enabling healthcare providers to maintain consistent operational efficiency and diagnostic quality.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
Chenghui Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Chenghui Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Chenghui Medical in its N-PORT filings yet. We sweep new filings monthly.